[1] 郑燕蓉, 林莉, 毛月.老年慢病共病人群中肌肉减少症患病情况研究[J].现代医学, 2022, 50(5):618-623.
[2] 健康中国行动推进委员会.健康中国行动(2019-2030年):总体要求、重大行动及主要指标[J].中国循环杂志, 2019, 34(9):846-858.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志, 2021, 41(8):668-695.
[4] 宁光.中国糖尿病防治的现状及展望[J].中国科学(生命科学), 2018, 48(8):810-811.
[5] 常文静, 蔡佳宇, 蔡辉.脂肪细胞因子、代谢综合征与风湿性疾病[J].现代医学, 2015, 43(2):256-262.
[6] SUNG K C, LEE M Y, KIM Y H, et al.Obesity and incidence of diabetes:effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver[J].Atherosclerosis, 2018, 275:50-57.
[7] XU S, MING J, JIA A, et al.Normal weight obesity and the risk of diabetes in Chinese people:a 9-year population-based cohort study[J].Sci Rep, 2021, 11(1):6090.
[8] LOW S, KHOO K C J, WANG J, et al.Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore[J].Endocrine, 2019, 65(1):73-80.
[9] VIJAN S.Type 2 diabetes[J].Ann Intern Med, 2020, 172(10):705.
[10] ZHAO Y, HU Y, SMITH J P, et al.Cohort profile:the China Health and Retirement Longitudinal Study(CHARLS)[J].Int J Epidemiol, 2014, 43(1):61-68.
[11] 中国超重肥胖医学营养治疗专家共识编写委员会.中国超重/肥胖医学营养治疗专家共识(2016年版)[J].糖尿病天地(临床), 2016, 10(10):451-455.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志, 2021, 41(9):757-784.
[13] WEI Y, WANG J, HAN X, et al.Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population[J].Diabetes Metab Res Rev, 2020, 36(1):e3202.
[14] SONG Z, GAO M, LV J, et al.Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults:the China Kadoorie Biobank[J].Eur J Endocrinol, 2022, 186(2):233-244.
[15] JANGHORBANI M, SALAMAT M R, AMINI M, et al.Risk of diabetes according to the metabolic health status and degree of obesity[J].Diabetes Metab Syndr, 2017, 11(Suppl 1):S439-S444.
[16] HUDISH L I, REUSCH J E, SUSSEL L.β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes[J].J Clin Invest, 2019, 129(10):4001-4008.
[17] BARKAS F, LIAMIS G, ELISAF M, et al.Metabolically healthy obesity and risk of incident type 2 diabetes in 1077 statin-treated individuals:a six-year retrospective study[J].Eur J Prev Cardiol, 2020, 27(19):2341-2344.
[18] ZHU X, HU J, GUO H, et al.Effect of metabolic health and obesity phenotype on risk of diabetes mellitus:a population-based longitudinal study[J].Diabetes Metab Syndr Obes, 2021, 14:3485-3498.
[19] NATARAJAN H, SHANTHI RANI C S, KRISHNA KUMAR D, et al.Future risk of diabetes among Indians with metabolic and phenotypic obesity:results from the 10-year follow-up of the Chennai Urban Rural Epidemiology Study(CURES-158)[J].Acta Diabetol, 2021, 58(8):1051-1058.
[20] YEH T L, HSU H Y, TSAI M C, et al.Association between metabolically healthy obesity/overweight and cardiovascular disease risk:a representative cohort study in Taiwan[J].PLoS One, 2021, 16(2):e0246378.
[21] WANG B, ZHANG M, WANG S, et al.Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus:a cohort study of a rural adult Chinese population[J].Obes Res Clin Pract, 2018, 12(1):61-71.
[22] SAXTON S N, CLARK B J, WITHERS S B, et al.Mechanistic links between obesity, diabetes, and blood pressure:role of perivascular adipose tissue[J].Physiol Rev, 2019, 99(4):1701-1763.
[23] ANTONOPOULOS A S, MARGARITISM, COUTINHO P, et al.Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall:the regulatory role of perivascular adipose tissue[J].Diabetes, 2015, 64(6):2207-2219.
[24] KASSI E, PERVANIDOU P, KALTSAS G, et al.Metabolic syndrome:definitions and controversies[J].BMC Med, 2011, 9:48. |